MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) Tariff Resilience Score: 0/10 (As of Jul. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IST:MEDTR MEDITERA TIBBI MALZEME SANAYI VE TICARET AS IST:MEDTR
79 GF Score
Price ₺27.32
GF Value ₺43.90
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is MEDITERA TIBBI MALZEMENAYI VE TICARET AS Tariff Resilience Score?

MEDITERA TIBBI MALZEMENAYI VE TICARET AS has the Tariff Resilience Score of 0, which implies that the company might have .

MEDITERA TIBBI MALZEMENAYI VE TICARET AS has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes MEDITERA TIBBI MALZEMENAYI VE TICARET AS might have .

MEDITERA TIBBI MALZEMENAYI VE TICARET AS  (IST:MEDTR) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Tariff Resilience Score Related Terms

IST:MEDTR
79GF Score
MEDITERA TIBBI MALZEME SANAYI VE TICARET AS IST:MEDTR
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) Overvalued in 2026?

Based on GuruFocus' analysis, MEDITERA TIBBI MALZEMENAYI VE TICARET AS stock appears to be undervalued. The current stock price of ₺27.32 is trading 37.8% below its estimated GF Value™ of ₺43.90. GuruFocus considers MEDITERA TIBBI MALZEMENAYI VE TICARET AS to be Significantly Undervalued.

Key valuation signals for IST:MEDTR:

  • Tariff Resilience Score: 0
  • GF Value™: ₺43.90 vs. price of ₺27.32 (37.8% below fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the IST:MEDTR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Business Description

Address Sokak No: 29 Tire Organize Sanayi, Ibni Melek OSB Mahallesi, TOSBI Yol 4, Bolgesi Tire, Izmir, TUR, 35900
MEDITERA TIBBI MALZEME SANAYI VE TICARET AS is engaged in the manufacture of anesthesia and intensive care circuits, the installation, operation, and design of oncology drug preparation and delivery systems, production, sales, and technical service of infusion pumps and sets, and the manufacture of biocidal products.
79GF Score

Get the complete analysis for IST:MEDTR

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺27.32
Price
₺43.90
GF Value